glp-1 news today nov 2025 As Drugs Go Mainstream, This Expert Says Health is More than a Number on a Scale GLP-1 Market Trends | Whitepaper

At six months, 50 to 60 percent of patients achieved a 1-point or higher reduction in HS Physician's Global Assessment

Find ud af, hvor du kan kbe det i Danmark!

This edit of wellness retreats, super supplements, and medical-grade devices, will help you feel and look your best.

Learn the long-term side effects.

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes The prescribing information for the generic liraglutide injection approved today includes a Boxed Warning to advise health care professionals and patients about the increased risk of thyroid C-cell tumors

The more meaningful question is not: Do patients regain weight after stopping GLP-1s? It is: How should we transition patients from pharmacologic support to long-term weight maintenance? Obesity is a chronic disease